protein CD14. CFTR mRNA was detected by RT-PCR using RNA isolated from purified murine bone marrowderived macrophages (BMM) raising the possibility of a macrophage autonomous phenotype in CF. Both S100A8 and TNFα are LPS-inducible in BMM. In experiments comparing induction of these two mRNAs in BMM derived from litter-mates, those from CF homozygous mice responded most rapidly and to lower LPS concentrations. Most importantly, the heterozygous animals also exhibited increased susceptibility to LPS compared to wild type. The effect of the CF homozygous mutation of maximal levels of TNFα mRNA and protein has been confirmed using thioglycollate-elicited peritoneal macrophages.
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In summary, we have shown that induction of S100A8/A9 mRNA is a lung-specific response to bacterial endotoxin and that CF mice are hypersensitive to LPS in terms of induction of this complex. We provide evidence that LPS hypersensitivity in CF is macrophage autonomous, and there is a phenotype in macrophages from heterozygous animals. The possibility that alveolar epithelial cells, which express S100A8 mRNA, are also hypersensitive to macrophage derived cytokines or direct effects of LPS is not precluded. The CF antigen dimer formed by S100A8 and S100A9 has been shown to be activated secreted and to have anti-microbial activity (see Rammes et al 4 ) so inducible secretion from epithelia, along with other defensins, may be a part of the lung antimicrobial defence. Previous workers have speculated upon a heterozygous advantage of the CF mutation in terms of resistance to enteric pathogens to explain the prevalence of mutant chromosomes in the Caucasian population. We suggest that the heterozygous state may also confer a more effective immune defence in the lungs. Enhanced defence against lung infection may be particularly relevant to fixation of CF mutations in the Caucasian population, who have evolved in climates in which lung diseases are a prevalent cause of early mortality. Recent studies have documented that LPS is brought to the membranes of responsive cells by the action of the lipid transport proteins, LBP and CD14. 1 This transport occurs in two steps. In the first, LBP attached to bacteria or LPS aggregates catalytically transfers an LPS monomer to a binding site on sCD14. sCD14 may then diffuse through the aqueous medium to the surface of a cell. The second essential step occurs at the cell surface and may involve either sCD14 or mCD14. sCD14 can interact directly with the cell surface, and this interaction predominates in cells that lack mCD14. In cells that express mCD14, the mCD14 may receive LPS monomers either by direct transfer from LPS aggregates mediated by LBP, or the LPS monomer may also be rapidly transferred from sCD14 to mCD14. In either case, the critical second step is release of LPS from CD14 into the lipid bilayer of cells. These two steps, binding of LPS monomer to CD14 and release of LPS monomer into the membrane, constitute the steps mediated by LBP and CD14 which appear necessary for cell stimulation. This assertion is strengthened by the observation that the need for LBP can be obviated by preforming LPS-sCD14 complexes, and the need for CD14 can be obviated by driving fusion of LPS into membranes either using fusogenic virosomes or very high concentrations of LPS. It should be noted that LPS aggregates and LPS-LBP complexes can be endocytosed by cells. In this setting, LPS remains topographically outside the cell (in lysosomes), and this process is not linked to stimulation of the inflammatory response: rather it represents a means for destroying LPS.
Innate recognition of bacterial LPS
The most important question in innate immunity is 'how do cells discriminate microbial lipids such as LPS from endogenous phospholipids?' Several lines of evidence indicate that neither LBP nor CD14 confers specificity in the interaction with LPS.
1 LPS can be discriminated from host lipids by cells in the absence of either LBP or CD14, and both LBP and CD14 show promiscuous interaction with a wide range of lipids in addition to biologically active LPS. It is, therefore, clear that the discrimination occurs after the fusion of LPS with the host plasma membrane. It is well known that cells recognize and sort lipids with subtle chemical differences, segregating sphingomyelin, for example, from the closely similar phosphatidyl choline. It is possible that similar types of lipid sorting might serve in innate recognition of microbial products. In keeping with this notion, we have noted that introduction of fluorescent LPS monomers into the plasma membranes of cells is followed by rapid transport of LPS to a perinuclear site. 2 This transport appears to discriminate biologically active from inactive LPS species, since inactive chemical homologues of LPS were not transported in this way. 3 The transport to the perinuclear site also appears necessary for cell stimulation since blocking of transport with inhibitors of vesicular transport prevented responses to LPS. 2 Moreover, this transport was absent from cells from mice with a genetic deficiency in responsiveness to LPS. 4 The mechanism for selective recognition and transport of LPS (or any membrane lipid) is not known at this time and is an area of active research.
Is LPS in membranes recognized as a monomer through stoichiometric, stereospecific binding with a defined binding partner or 'receptor?' This sentiment dominates the field, but another alternative must be considered. LPS might be recognized not as a monomer but as an array, or complex with itself or other membrane lipids. In this model, the spacing of groups and/or the collective properties of the complex are the features of LPS recognized by cells. An argument in favor of this hypothesis is the observation that deacylation of LPS changes not only the hydrophilic/lipophilic balance of the molecules but also transforms LPS from an agonist to an antagonist. Moreover, a small hydrophobic region is a common property of LPS antagonists such as Rhodobacter sphaeroides LPS (RsLPS). The composition and size of the hydrophobic portion of LPS will have large effects on its interaction with a plasma lipid bilayer. To test the hypothesis that the hydrophobic mass of LPS contributes to its recognition by cells, we have added the membrane-active agent chlorpromazine to cells treated with RsLPS. Chlorpromazine has a very large hydrophobic region and a small, cationic hydrophilic region. We observed that chlorpromazine both restored the ability of RsLPS to be transported to a perinuclear area and restored the ability of RsLPS to initiate cellular responses. 3 These studies make it clear that the properties of the membrane bearing LPS are key to recognition. They suggest first, that LPS, because of its large hydrophobic areas, may alter the physical properties of a membrane in which it resides and, thereby, initiate cellular responses. It further suggests that cellular responses may not require a stoichiometric, stereospecific interaction with a receptor since recognition normally enabled by covalently linked acyl chains (the 'piggy-backed fatty acids') can apparently be substituted by the noncovalently linked heterocyclic group of chlorpromazine. The ability to make such a drastic substitution is not consistent with the action of a classical receptor of high specificity and affinity. For these reasons, we prefer the hypothesis that cells discriminate bacterial lipids from host lipids on the basis of their interaction with and packing within a host lipid bilayer.
